𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer

✍ Scribed by Zhiqiang Meng; Peiying Yang; Yehua Shen; Wenying Bei; Ying Zhang; Yongqian Ge; Robert A. Newman; Lorenzo Cohen; Luming Liu; Bob Thornton; David Z. Chang; Zongxing Liao; Razelle Kurzrock

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
293 KB
Volume
115
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase 1 trial of everolimus and gefitini
Phase 1 trial of everolimus and gefitinib in patients with advanced nonsmall-cell lung cancer
✍ Daniel T. Milton; Gregory J. Riely; Christopher G. Azzoli; Jorge E. Gomez; Rober πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 123 KB πŸ‘ 3 views

## Abstract ## BACKGROUND. Preclinical studies have demonstrated that the inhibition of the PI3K/Akt/mTOR pathway restores gefitinib sensitivity in resistant cancer cell lines. A phase 1 study was conducted of the combination of everolimus, an mTOR inhibitor, and gefitinib to determine a daily dos

The value of combined-modality therapy i
The value of combined-modality therapy in elderly patients with stage III nonsmall cell lung cancer
✍ Steven E. Schild; Sumithra J. Mandrekar; Aminah Jatoi; William L. McGinnis; Phil πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 140 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. The objective of this study was to assess the value of combined‐modality therapy in elderly patients by comparing the differences in outcome between patients who received radiotherapy (RT) alone and patients who received RT plus chemotherapy for stage III nonsmall cell l

Prospective randomized study of four nov
Prospective randomized study of four novel chemotherapy regimens in patients with advanced nonsmall cell lung carcinoma : A Minnie Pearl Cancer Research Network trial
✍ F. Anthony Greco; James R. Gray Jr.; Dana S. Thompson; Howard A. Burris III; Joa πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 80 KB πŸ‘ 1 views

## Abstract ## BACKGROUND The authors compared the toxicity, response rate, and progression free survival of four chemotherapy regimens for patients with advanced (Stage IIIB and IV) nonsmall cell lung carcinoma. ## METHODS A total of 267 patients entered this randomized Phase II trial on one of